应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
SPRB Spruce Biosciences, Inc.
未开盘 04-17 16:00:00 EDT
0.1187
-0.0043
-3.50%
盘后
0.1139
-0.0048
-4.04%
19:50 EDT
最高
0.1256
最低
0.1100
成交量
398.11万
今开
0.1250
昨收
0.1230
日振幅
12.68%
总市值
501.29万
流通市值
292.16万
总股本
4,223万
成交额
46.53万
换手率
16.17%
流通股本
2,461万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
资讯
新帖
简况
Spruce Biosciences, Inc.盘中异动 早盘大幅跳水6.50%
市场透视 · 04-17
Spruce Biosciences, Inc.盘中异动 早盘大幅跳水6.50%
加拿大皇家银行:维持Spruce Biosciences(SPRB.US)评级,由与大盘持平调整至与大盘持平评级, 目标价由1.50美元调整至0.50美元。
金融界 · 04-16
加拿大皇家银行:维持Spruce Biosciences(SPRB.US)评级,由与大盘持平调整至与大盘持平评级, 目标价由1.50美元调整至0.50美元。
Spruce Biosciences, Inc.盘中异动 早盘快速下跌5.30%
市场透视 · 04-16
Spruce Biosciences, Inc.盘中异动 早盘快速下跌5.30%
Spruce Biosciences, Inc.盘中异动 大幅下挫9.23%报0.353美元
市场透视 · 03-03
Spruce Biosciences, Inc.盘中异动 大幅下挫9.23%报0.353美元
Spruce Biosciences, Inc.盘中异动 早盘股价大涨6.13%报0.405美元
市场透视 · 02-28
Spruce Biosciences, Inc.盘中异动 早盘股价大涨6.13%报0.405美元
Spruce Biosciences, Inc.盘中异动 股价大跌5.12%报0.399美元
市场透视 · 02-24
Spruce Biosciences, Inc.盘中异动 股价大跌5.12%报0.399美元
Spruce Biosciences, Inc.盘中异动 早盘股价大跌5.67%报0.401美元
市场透视 · 02-21
Spruce Biosciences, Inc.盘中异动 早盘股价大跌5.67%报0.401美元
Spruce Biosciences, Inc.盘中异动 股价大跌6.04%
市场透视 · 02-18
Spruce Biosciences, Inc.盘中异动 股价大跌6.04%
Spruce Biosciences, Inc.盘中异动 临近午盘大幅跳水6.19%报0.381美元
市场透视 · 02-10
Spruce Biosciences, Inc.盘中异动 临近午盘大幅跳水6.19%报0.381美元
Spruce Biosciences, Inc.盘中异动 早盘大幅拉升5.32%报0.400美元
市场透视 · 02-04
Spruce Biosciences, Inc.盘中异动 早盘大幅拉升5.32%报0.400美元
Spruce Biosciences, Inc.盘中异动 下午盘股价大跌5.77%报0.358美元
市场透视 · 01-29
Spruce Biosciences, Inc.盘中异动 下午盘股价大跌5.77%报0.358美元
Spruce Biosciences, Inc.盘中异动 早盘快速下跌6.01%
市场透视 · 01-17
Spruce Biosciences, Inc.盘中异动 早盘快速下跌6.01%
Spruce Biosciences, Inc.盘中异动 快速拉升6.59%
市场透视 · 01-14
Spruce Biosciences, Inc.盘中异动 快速拉升6.59%
Spruce Biosciences, Inc.盘中异动 早盘急速下跌5.38%
市场透视 · 01-13
Spruce Biosciences, Inc.盘中异动 早盘急速下跌5.38%
Spruce Biosciences, Inc.盘中异动 大幅下跌6.17%
市场透视 · 01-06
Spruce Biosciences, Inc.盘中异动 大幅下跌6.17%
Spruce Biosciences, Inc.盘中异动 早盘股价大跌6.29%报0.410美元
市场透视 · 2024-12-30
Spruce Biosciences, Inc.盘中异动 早盘股价大跌6.29%报0.410美元
Spruce Biosciences, Inc.盘中异动 快速拉升5.89%
市场透视 · 2024-12-26
Spruce Biosciences, Inc.盘中异动 快速拉升5.89%
Spruce Biosciences, Inc.盘中异动 快速上涨5.91%报0.400美元
市场透视 · 2024-12-24
Spruce Biosciences, Inc.盘中异动 快速上涨5.91%报0.400美元
Spruce Biosciences, Inc.盘中异动 早盘股价大跌5.05%
市场透视 · 2024-12-23
Spruce Biosciences, Inc.盘中异动 早盘股价大跌5.05%
Spruce Biosciences, Inc.盘中异动 下午盘股价大跌5.76%报0.381美元
市场透视 · 2024-12-18
Spruce Biosciences, Inc.盘中异动 下午盘股价大跌5.76%报0.381美元
加载更多
公司概况
公司名称:
Spruce Biosciences, Inc.
所属市场:
NASDAQ
上市日期:
--
主营业务:
Spruce Biosciences, Inc.最初于2014年11月在特拉华州成立为一家有限责任公司。该公司是一家处于后期阶段的生物制药公司,专注于开发和商业化治疗罕见的内分泌疾病的新疗法,这些疾病的医疗需求尚未得到满足。该公司正在初步开发全资候选产品tildacerfont,作为潜在的第一个非甾体疗法,为患有典型先天性肾上腺增生症的患者提供显著改善的疾病控制和减少类固醇负担。
发行价格:
--
{"stockData":{"symbol":"SPRB","market":"US","secType":"STK","nameCN":"Spruce Biosciences, Inc.","latestPrice":0.1187,"timestamp":1744920000000,"preClose":0.123,"halted":0,"volume":3981053,"hourTrading":{"tag":"盘后","latestPrice":0.1139,"preClose":0.1187,"latestTime":"19:50 EDT","volume":33171,"amount":3844.109008,"timestamp":1744933827316},"delay":0,"floatShares":24613161,"shares":42231285,"eps":-1.285255,"marketStatus":"未开盘","change":-0.0043,"latestTime":"04-17 16:00:00 EDT","open":0.125,"high":0.1256,"low":0.11,"amount":465280.290498722,"amplitude":0.126829,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-1.285255,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1745222400000},"marketStatusCode":0,"adr":0,"listingDate":1602216000000,"exchange":"NASDAQ","adjPreClose":0.123,"preHourTrading":{"tag":"盘前","latestPrice":0.1242,"preClose":0.123,"latestTime":"09:25 EDT","volume":42826,"amount":5186.4423017399995,"timestamp":1744896358870},"postHourTrading":{"tag":"盘后","latestPrice":0.1139,"preClose":0.1187,"latestTime":"19:50 EDT","volume":33171,"amount":3844.109008,"timestamp":1744933827316},"volumeRatio":0.5574266429641613,"impliedVol":1.3563,"impliedVolPercentile":0.3506},"requestUrl":"/m/hq/s/SPRB","defaultTab":"news","newsList":[{"id":"2528845746","title":"Spruce Biosciences, Inc.盘中异动 早盘大幅跳水6.50%","url":"https://stock-news.laohu8.com/highlight/detail?id=2528845746","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2528845746?lang=zh_cn&edition=full","pubTime":"2025-04-17 22:00","pubTimestamp":1744898431,"startTime":"0","endTime":"0","summary":"北京时间2025年04月17日22时00分,Spruce Biosciences, Inc.股票出现异动,股价急速下挫6.50%。Spruce Biosciences, Inc.股票所在的生物技术行业中,整体涨幅为0.65%。其相关个股中,Channel Therapeutics Corporation、Uniqure N.V.、硕迪生物涨幅较大,Channel Therapeutics Corporation、Clearmind Medicine Inc.、Transcode Therapeutics, Inc.较为活跃,换手率分别为503.85%、155.13%、87.30%,振幅较大的相关个股有Processa Pharmaceuticals, Inc.、Channel Therapeutics Corporation、Prokidney Corp.,振幅分别为43.27%、37.45%、20.47%。Spruce Biosciences, Inc.公司简介:Spruce Biosciences Inc 是一家后期生物制药公司,专注于开发和商业化针对未满足医疗需求的罕见内分泌疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250417220031973b5970&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250417220031973b5970&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","SPRB"],"gpt_icon":0},{"id":"2527967225","title":"加拿大皇家银行:维持Spruce Biosciences(SPRB.US)评级,由与大盘持平调整至与大盘持平评级, 目标价由1.50美元调整至0.50美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2527967225","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2527967225?lang=zh_cn&edition=full","pubTime":"2025-04-16 23:44","pubTimestamp":1744818288,"startTime":"0","endTime":"0","summary":"加拿大皇家银行:维持Spruce Biosciences(SPRB.US)评级,由与大盘持平调整至与大盘持平评级, 目标价由1.50美元调整至0.50美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/04/16234449603229.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["SPRB"],"gpt_icon":0},{"id":"2527043245","title":"Spruce Biosciences, Inc.盘中异动 早盘快速下跌5.30%","url":"https://stock-news.laohu8.com/highlight/detail?id=2527043245","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2527043245?lang=zh_cn&edition=full","pubTime":"2025-04-16 21:50","pubTimestamp":1744811439,"startTime":"0","endTime":"0","summary":"北京时间2025年04月16日21时50分,Spruce Biosciences, Inc.股票出现波动,股价大幅下挫5.30%。Spruce Biosciences, Inc.股票所在的生物技术行业中,整体跌幅为1.09%。其相关个股中,Dermata Therapeutics Inc C/Wts 、Psyence Biomedical Ltd C/Wts 25/01/2029、Briacell Therapeutics Corp.涨幅较大,Briacell Therapeutics Corp.、Pmgc Holdings Inc.、Transcode Therapeutics, Inc.较为活跃,换手率分别为429.79%、150.87%、65.23%,振幅较大的相关个股有Mei Pharma, Inc.、Quoin Pharmaceuticals Ltd、天演药业,振幅分别为29.90%、29.30%、22.50%。Spruce Biosciences, Inc.公司简介:Spruce Biosciences Inc 是一家后期生物制药公司,专注于开发和商业化针对未满足医疗需求的罕见内分泌疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025041621504094d787a7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025041621504094d787a7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","SPRB"],"gpt_icon":0},{"id":"2516632349","title":"Spruce Biosciences, Inc.盘中异动 大幅下挫9.23%报0.353美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516632349","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2516632349?lang=zh_cn&edition=full","pubTime":"2025-03-03 22:32","pubTimestamp":1741012321,"startTime":"0","endTime":"0","summary":"北京时间2025年03月03日22时32分,Spruce Biosciences, Inc.股票出现异动,股价大幅跳水9.23%。Spruce Biosciences, Inc.股票所在的生物技术行业中,整体涨幅为0.21%。其相关个股中,Entero Therapeutics Inc.、Alto Neuroscience, Inc.、Geovax Labs, Inc.涨幅较大,Allarity Therapeutics, Inc.、Entero Therapeutics Inc.、Aeon Biopharma, Inc.较为活跃,换手率分别为47.26%、26.91%、22.55%,振幅较大的相关个股有Entero Therapeutics Inc.、Spruce Biosciences, Inc.、Cibus, Inc.,振幅分别为21.22%、19.25%、9.55%。Spruce Biosciences, Inc.公司简介:Spruce Biosciences Inc 是一家后期生物制药公司,专注于开发和商业化针对未满足医疗需求的罕见内分泌疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303223201abe63345&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303223201abe63345&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SPRB","BK4139"],"gpt_icon":0},{"id":"2514378974","title":"Spruce Biosciences, Inc.盘中异动 早盘股价大涨6.13%报0.405美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514378974","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514378974?lang=zh_cn&edition=full","pubTime":"2025-02-28 22:33","pubTimestamp":1740753182,"startTime":"0","endTime":"0","summary":"北京时间2025年02月28日22时33分,Spruce Biosciences, Inc.股票出现波动,股价急速上涨6.13%。截至发稿,该股报0.405美元/股,成交量1.7316万股,换手率0.04%,振幅6.62%。Spruce Biosciences, Inc.股票所在的生物技术行业中,整体跌幅为0.12%。Spruce Biosciences, Inc.公司简介:Spruce Biosciences Inc 是一家后期生物制药公司,专注于开发和商业化针对未满足医疗需求的罕见内分泌疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228223302abe0eaf0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228223302abe0eaf0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","SPRB"],"gpt_icon":0},{"id":"2513773326","title":"Spruce Biosciences, Inc.盘中异动 股价大跌5.12%报0.399美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2513773326","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2513773326?lang=zh_cn&edition=full","pubTime":"2025-02-24 23:08","pubTimestamp":1740409726,"startTime":"0","endTime":"0","summary":"北京时间2025年02月24日23时08分,Spruce Biosciences, Inc.股票出现异动,股价快速下挫5.12%。截至发稿,该股报0.399美元/股,成交量9.7834万股,换手率0.24%,振幅3.95%。Spruce Biosciences, Inc.股票所在的生物技术行业中,整体涨幅为0.64%。Spruce Biosciences, Inc.公司简介:Spruce Biosciences Inc 是一家后期生物制药公司,专注于开发和商业化针对未满足医疗需求的罕见内分泌疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224230847abdb16f7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224230847abdb16f7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SPRB","BK4139"],"gpt_icon":0},{"id":"2513961772","title":"Spruce Biosciences, Inc.盘中异动 早盘股价大跌5.67%报0.401美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2513961772","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2513961772?lang=zh_cn&edition=full","pubTime":"2025-02-21 22:31","pubTimestamp":1740148295,"startTime":"0","endTime":"0","summary":"北京时间2025年02月21日22时31分,Spruce Biosciences, Inc.股票出现异动,股价大幅下挫5.67%。截至发稿,该股报0.401美元/股,成交量1.7247万股,换手率0.04%,振幅0.00%。Spruce Biosciences, Inc.股票所在的生物技术行业中,整体涨幅为0.33%。Spruce Biosciences, Inc.公司简介:Spruce Biosciences Inc 是一家后期生物制药公司,专注于开发和商业化针对未满足医疗需求的罕见内分泌疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250221223136a24eb02f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250221223136a24eb02f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SPRB","BK4139"],"gpt_icon":0},{"id":"2512016528","title":"Spruce Biosciences, Inc.盘中异动 股价大跌6.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2512016528","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2512016528?lang=zh_cn&edition=full","pubTime":"2025-02-18 22:33","pubTimestamp":1739889202,"startTime":"0","endTime":"0","summary":"北京时间2025年02月18日22时33分,Spruce Biosciences, Inc.股票出现波动,股价快速下挫6.04%。Spruce Biosciences, Inc.股票所在的生物技术行业中,整体跌幅为0.08%。其相关个股中,Solid Biosciences Inc.、Revolution Medicines Inc C/Wts 17/12/2026 、Glycomimetics, Inc.涨幅较大,Aditxt, Inc.、Solid Biosciences Inc.、Moleculin Biotech, Inc.较为活跃,换手率分别为279.48%、96.30%、72.32%,振幅较大的相关个股有Jasper Therapeutics Inc C/Wts 24/09/2026 、Allogene Therapeutics, Inc.、Solid Biosciences Inc.,振幅分别为34.04%、22.30%、18.61%。Spruce Biosciences, Inc.公司简介:Spruce Biosciences Inc 是一家后期生物制药公司,专注于开发和商业化针对未满足医疗需求的罕见内分泌疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250218223322abd3af9e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250218223322abd3af9e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SPRB","BK4139"],"gpt_icon":0},{"id":"2510671838","title":"Spruce Biosciences, Inc.盘中异动 临近午盘大幅跳水6.19%报0.381美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2510671838","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2510671838?lang=zh_cn&edition=full","pubTime":"2025-02-11 00:31","pubTimestamp":1739205114,"startTime":"0","endTime":"0","summary":"北京时间2025年02月11日00时31分,Spruce Biosciences, Inc.股票出现异动,股价快速下跌6.19%。截至发稿,该股报0.381美元/股,成交量5.3938万股,换手率0.13%,振幅7.20%。Spruce Biosciences, Inc.股票所在的生物技术行业中,整体跌幅为0.08%。Spruce Biosciences, Inc.公司简介:Spruce Biosciences Inc 是一家后期生物制药公司,专注于开发和商业化针对未满足医疗需求的罕见内分泌疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250211003154abc9bf16&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250211003154abc9bf16&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SPRB","BK4139"],"gpt_icon":0},{"id":"2509660744","title":"Spruce Biosciences, Inc.盘中异动 早盘大幅拉升5.32%报0.400美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2509660744","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2509660744?lang=zh_cn&edition=full","pubTime":"2025-02-05 00:14","pubTimestamp":1738685679,"startTime":"0","endTime":"0","summary":"北京时间2025年02月05日00时14分,Spruce Biosciences, Inc.股票出现波动,股价快速上涨5.32%。Spruce Biosciences, Inc.股票所在的生物技术行业中,整体涨幅为1.33%。其相关个股中,Estrella Immunopharma Inc C/Wts 29/09/2028、Azitra Inc、Evaxion Biotech As涨幅较大,Azitra Inc、Evaxion Biotech As、Quoin Pharmaceuticals Ltd较为活跃,换手率分别为1628.21%、924.76%、439.00%,振幅较大的相关个股有Azitra Inc、Lakeshore Biopharma Co Ltd C/Wts 15/03/2028 、Quoin Pharmaceuticals Ltd,振幅分别为72.82%、49.88%、47.29%。Spruce Biosciences, Inc.公司简介:Spruce Biosciences Inc 是一家后期生物制药公司,专注于开发和商业化针对未满足医疗需求的罕见内分泌疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250205001440a2393cbe&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250205001440a2393cbe&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SPRB","BK4139"],"gpt_icon":0},{"id":"2507496652","title":"Spruce Biosciences, Inc.盘中异动 下午盘股价大跌5.77%报0.358美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2507496652","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2507496652?lang=zh_cn&edition=full","pubTime":"2025-01-30 03:12","pubTimestamp":1738177927,"startTime":"0","endTime":"0","summary":"北京时间2025年01月30日03时12分,Spruce Biosciences, Inc.股票出现异动,股价急速下跌5.77%。截至发稿,该股报0.358美元/股,成交量30.6329万股,换手率0.74%,振幅3.95%。Spruce Biosciences, Inc.股票所在的生物技术行业中,整体涨幅为0.97%。Spruce Biosciences, Inc.公司简介:Spruce Biosciences Inc 是一家后期生物制药公司,专注于开发和商业化针对未满足医疗需求的罕见内分泌疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501300312079613b58d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501300312079613b58d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","SPRB"],"gpt_icon":0},{"id":"2504195546","title":"Spruce Biosciences, Inc.盘中异动 早盘快速下跌6.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2504195546","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2504195546?lang=zh_cn&edition=full","pubTime":"2025-01-17 23:54","pubTimestamp":1737129271,"startTime":"0","endTime":"0","summary":"北京时间2025年01月17日23时54分,Spruce Biosciences, Inc.股票出现波动,股价快速下挫6.01%。Spruce Biosciences, Inc.股票所在的生物技术行业中,整体涨幅为0.74%。Spruce Biosciences, Inc.公司简介:Spruce Biosciences Inc 是一家后期生物制药公司,专注于开发和商业化针对未满足医疗需求的罕见内分泌疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501172354319607abc7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501172354319607abc7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SPRB","BK4139"],"gpt_icon":0},{"id":"2503157465","title":"Spruce Biosciences, Inc.盘中异动 快速拉升6.59%","url":"https://stock-news.laohu8.com/highlight/detail?id=2503157465","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2503157465?lang=zh_cn&edition=full","pubTime":"2025-01-14 22:46","pubTimestamp":1736865996,"startTime":"0","endTime":"0","summary":"北京时间2025年01月14日22时46分,Spruce Biosciences, Inc.股票出现异动,股价急速拉升6.59%。Spruce Biosciences, Inc.股票所在的生物技术行业中,整体跌幅为0.34%。其相关个股中,Eterna Therapeutics Inc.、Seastar Medical Holding Corp C/Wts 28/10/2027 、Jasper Therapeutics Inc C/Wts 24/09/2026 涨幅较大,Soligenix, Inc.、Phio Pharmaceuticals Corp.、Eterna Therapeutics Inc.较为活跃,换手率分别为364.14%、312.17%、226.00%,振幅较大的相关个股有Eterna Therapeutics Inc.、Klotho Neurosciences Inc C/Wts 21/06/2029 、Soligenix, Inc.,振幅分别为86.57%、34.18%、24.92%。Spruce Biosciences, Inc.公司简介:Spruce Biosciences Inc 是一家后期生物制药公司,专注于开发和商业化针对未满足医疗需求的罕见内分泌疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250114224636abaab07d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250114224636abaab07d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SPRB","BK4139"],"gpt_icon":0},{"id":"2503458798","title":"Spruce Biosciences, Inc.盘中异动 早盘急速下跌5.38%","url":"https://stock-news.laohu8.com/highlight/detail?id=2503458798","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2503458798?lang=zh_cn&edition=full","pubTime":"2025-01-14 00:07","pubTimestamp":1736784439,"startTime":"0","endTime":"0","summary":"北京时间2025年01月14日00时07分,Spruce Biosciences, Inc.股票出现异动,股价大幅下跌5.38%。Spruce Biosciences, Inc.股票所在的生物技术行业中,整体跌幅为1.02%。其相关个股中,Phio Pharmaceuticals Corp.、Salarius Pharmaceuticals, Inc.、Kairos Pharma, Ltd.涨幅较大,Phio Pharmaceuticals Corp.、Salarius Pharmaceuticals, Inc.、Silexion Therapeutics Corp较为活跃,换手率分别为11173.57%、6043.08%、424.28%,振幅较大的相关个股有Phio Pharmaceuticals Corp.、Salarius Pharmaceuticals, Inc.、Kairos Pharma, Ltd.,振幅分别为336.09%、216.61%、124.54%。Spruce Biosciences, Inc.公司简介:Spruce Biosciences Inc 是一家后期生物制药公司,专注于开发和商业化针对未满足医疗需求的罕见内分泌疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501140007199602642f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501140007199602642f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SPRB","BK4139"],"gpt_icon":0},{"id":"2501029608","title":"Spruce Biosciences, Inc.盘中异动 大幅下跌6.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2501029608","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2501029608?lang=zh_cn&edition=full","pubTime":"2025-01-07 02:53","pubTimestamp":1736189614,"startTime":"0","endTime":"0","summary":"北京时间2025年01月07日02时53分,Spruce Biosciences, Inc.股票出现波动,股价急速跳水6.17%。Spruce Biosciences, Inc.股票所在的生物技术行业中,整体涨幅为0.41%。其相关个股中,Scisparc Ltd.、Unity Biotechnology, Inc.、Rocket Pharmaceuticals Inc C/Wts 02/09/2026 涨幅较大,Scisparc Ltd.、Cns Pharmaceuticals, Inc.、Aeon Biopharma, Inc.较为活跃,换手率分别为1677.26%、383.04%、173.78%,振幅较大的相关个股有Scisparc Ltd.、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 、Ocean Biomedical Inc C/Wts 14/02/2028 ,振幅分别为176.15%、106.67%、92.16%。Spruce Biosciences, Inc.公司简介:Spruce Biosciences Inc 是一家后期生物制药公司,专注于开发和商业化针对未满足医疗需求的罕见内分泌疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025010702533495faa13d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025010702533495faa13d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SPRB","BK4139"],"gpt_icon":0},{"id":"2495982521","title":"Spruce Biosciences, Inc.盘中异动 早盘股价大跌6.29%报0.410美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2495982521","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2495982521?lang=zh_cn&edition=full","pubTime":"2024-12-30 23:00","pubTimestamp":1735570804,"startTime":"0","endTime":"0","summary":"北京时间2024年12月30日23时00分,Spruce Biosciences, Inc.股票出现波动,股价急速下跌6.29%。截至发稿,该股报0.410美元/股,成交量9.6756万股,换手率0.23%,振幅5.17%。Spruce Biosciences, Inc.股票所在的生物技术行业中,整体跌幅为1.26%。Spruce Biosciences, Inc.公司简介:Spruce Biosciences Inc 是一家后期生物制药公司,专注于开发和商业化针对未满足医疗需求的罕见内分泌疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241230230004ab982cdf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241230230004ab982cdf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SPRB","BK4139"],"gpt_icon":0},{"id":"2494422893","title":"Spruce Biosciences, Inc.盘中异动 快速拉升5.89%","url":"https://stock-news.laohu8.com/highlight/detail?id=2494422893","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2494422893?lang=zh_cn&edition=full","pubTime":"2024-12-27 01:44","pubTimestamp":1735235071,"startTime":"0","endTime":"0","summary":"北京时间2024年12月27日01时44分,Spruce Biosciences, Inc.股票出现异动,股价急速拉升5.89%。Spruce Biosciences, Inc.股票所在的生物技术行业中,整体涨幅为0.26%。其相关个股中,Moolec Science Sa C/Wts 、Scisparc Ltd.、Sab Biotherapeutics Inc C/Wts 22/10/2026 涨幅较大,Scisparc Ltd.、Coeptis Therapeutics Holdings, Inc.、Hoth Therapeutics, Inc.较为活跃,换手率分别为2010.63%、455.00%、116.31%,振幅较大的相关个股有Moolec Science Sa C/Wts 、Scisparc Ltd.、Nkgen Biotech Inc C/Wts 31/05/2028,振幅分别为264.57%、198.24%、131.78%。Spruce Biosciences, Inc.公司简介:Spruce Biosciences Inc 是一家后期生物制药公司,专注于开发和商业化针对未满足医疗需求的罕见内分泌疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024122701443298506bbb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024122701443298506bbb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SPRB","BK4139"],"gpt_icon":0},{"id":"2494031019","title":"Spruce Biosciences, Inc.盘中异动 快速上涨5.91%报0.400美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2494031019","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2494031019?lang=zh_cn&edition=full","pubTime":"2024-12-25 01:14","pubTimestamp":1735060468,"startTime":"0","endTime":"0","summary":"北京时间2024年12月25日01时14分,Spruce Biosciences, Inc.股票出现波动,股价大幅上涨5.91%。Spruce Biosciences, Inc.股票所在的生物技术行业中,整体涨幅为0.17%。Spruce Biosciences, Inc.公司简介:Spruce Biosciences Inc 是一家后期生物制药公司,专注于开发和商业化针对未满足医疗需求的罕见内分泌疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241225011429984da251&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241225011429984da251&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","SPRB"],"gpt_icon":0},{"id":"2493764979","title":"Spruce Biosciences, Inc.盘中异动 早盘股价大跌5.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2493764979","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2493764979?lang=zh_cn&edition=full","pubTime":"2024-12-23 22:32","pubTimestamp":1734964367,"startTime":"0","endTime":"0","summary":"北京时间2024年12月23日22时32分,Spruce Biosciences, Inc.股票出现波动,股价大幅下跌5.05%。Spruce Biosciences, Inc.股票所在的生物技术行业中,整体涨幅为0.06%。其相关个股中,Traws Pharma, Inc.、Rapt Therapeutics, Inc.、Gt Biopharma, Inc.涨幅较大,Phio Pharmaceuticals Corp.、Gt Biopharma, Inc.、Traws Pharma, Inc.较为活跃,换手率分别为666.04%、442.51%、291.19%,振幅较大的相关个股有Traws Pharma, Inc.、Gt Biopharma, Inc.、Neurosense Therapeutics Ltd.,振幅分别为36.65%、33.81%、19.04%。Spruce Biosciences, Inc.公司简介:Spruce Biosciences Inc 是一家后期生物制药公司,专注于开发和商业化针对未满足医疗需求的罕见内分泌疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241223223247ab8e40eb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241223223247ab8e40eb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SPRB","BK4139"],"gpt_icon":0},{"id":"2492715661","title":"Spruce Biosciences, Inc.盘中异动 下午盘股价大跌5.76%报0.381美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2492715661","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2492715661?lang=zh_cn&edition=full","pubTime":"2024-12-19 04:28","pubTimestamp":1734553717,"startTime":"0","endTime":"0","summary":"北京时间2024年12月19日04时28分,Spruce Biosciences, Inc.股票出现异动,股价快速下挫5.76%。截至发稿,该股报0.381美元/股,成交量48.8453万股,换手率1.18%,振幅8.48%。Spruce Biosciences, Inc.股票所在的生物技术行业中,整体跌幅为2.38%。Spruce Biosciences, Inc.公司简介:Spruce Biosciences Inc 是一家后期生物制药公司,专注于开发和商业化针对未满足医疗需求的罕见内分泌疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241219042837ab829aeb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241219042837ab829aeb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","SPRB"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.sprucebiosciences.com","stockEarnings":[{"period":"1week","weight":-0.5978},{"period":"1month","weight":-0.6356},{"period":"3month","weight":-0.6746},{"period":"6month","weight":-0.7713},{"period":"1year","weight":-0.8319},{"period":"ytd","weight":-0.7174}],"compareEarnings":[{"period":"1week","weight":0.0035},{"period":"1month","weight":-0.0617},{"period":"3month","weight":-0.1191},{"period":"6month","weight":-0.0995},{"period":"1year","weight":0.0517},{"period":"ytd","weight":-0.1018}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Spruce Biosciences, Inc.最初于2014年11月在特拉华州成立为一家有限责任公司。该公司是一家处于后期阶段的生物制药公司,专注于开发和商业化治疗罕见的内分泌疾病的新疗法,这些疾病的医疗需求尚未得到满足。该公司正在初步开发全资候选产品tildacerfont,作为潜在的第一个非甾体疗法,为患有典型先天性肾上腺增生症的患者提供显著改善的疾病控制和减少类固醇负担。","yearOnYearQuotes":[{"month":1,"riseRate":0.4,"avgChangeRate":0.250484},{"month":2,"riseRate":0.6,"avgChangeRate":0.014969},{"month":3,"riseRate":0,"avgChangeRate":-0.288755},{"month":4,"riseRate":0,"avgChangeRate":-0.18126},{"month":5,"riseRate":0.5,"avgChangeRate":-0.003763},{"month":6,"riseRate":0.25,"avgChangeRate":-0.126985},{"month":7,"riseRate":0.5,"avgChangeRate":-0.017508},{"month":8,"riseRate":0.25,"avgChangeRate":-0.021147},{"month":9,"riseRate":0.5,"avgChangeRate":-0.141116},{"month":10,"riseRate":0.25,"avgChangeRate":-0.193698},{"month":11,"riseRate":0.6,"avgChangeRate":0.019777},{"month":12,"riseRate":0.4,"avgChangeRate":0.287216}],"exchange":"NASDAQ","name":"Spruce Biosciences, Inc.","nameEN":"Spruce Biosciences, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.33.2","shortVersion":"4.33.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Spruce Biosciences, Inc.(SPRB)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Spruce Biosciences, Inc.(SPRB)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Spruce Biosciences, Inc.,SPRB,Spruce Biosciences, Inc.股票,Spruce Biosciences, Inc.股票老虎,Spruce Biosciences, Inc.股票老虎国际,Spruce Biosciences, Inc.行情,Spruce Biosciences, Inc.股票行情,Spruce Biosciences, Inc.股价,Spruce Biosciences, Inc.股市,Spruce Biosciences, Inc.股票价格,Spruce Biosciences, Inc.股票交易,Spruce Biosciences, Inc.股票购买,Spruce Biosciences, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Spruce Biosciences, Inc.(SPRB)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Spruce Biosciences, Inc.(SPRB)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}